Back
Seres Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
2
MCRB
Seres Therapeutics, Inc.
Last Price:
$8.56
Seasonality Move:
-13.01%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing buying pressure, which is a positive indicator for future bullish movement.
Seres Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.62 | Sell |
| 20-day SMA: | 13.17 | Sell |
| 50-day SMA: | 14.64 | Sell |
| 200-day SMA: | 14.54 | Sell |
| 8-day EMA: | 10.12 | Sell |
| 20-day EMA: | 12.27 | Sell |
| 50-day EMA: | 14.21 | Sell |
| 200-day EMA: | 15.51 | Sell |
Seres Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.79 | Sell |
| Relative Strength Index (14 RSI): | 26.81 | Sell |
| Chaikin Money Flow: | 63149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.93 - 16.33) | Sell |
| Bollinger Bands (100): | (13.33 - 19.43) | Sell |
Seres Therapeutics, Inc. Technical Analysis
| Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Seres Therapeutics, Inc. Stock
Is Seres Therapeutics, Inc. Stock a Buy?
-
Seres Therapeutics, Inc. share price is 8.74 while MCRB 8-day simple moving average is 10.62, which is a Sell signal.
-
The stock price of MCRB is 8.74 while Seres Therapeutics, Inc. 20-day SMA is 13.17, which makes it a Sell.
-
Seres Therapeutics, Inc. 50-day simple moving average is 14.64 while MCRB share price is 8.74, making it a Sell technically.
-
MCRB stock price is 8.74 and Seres Therapeutics, Inc. 200-day simple moving average is 14.54, creating a Sell signal.
MCRB Technical Analysis vs Fundamental Analysis
Sell
2
Seres Therapeutics, Inc. (MCRB)
is a Sell
Is Seres Therapeutics, Inc. a Buy or a Sell?
-
Seres Therapeutics, Inc. stock is rated a SellThe current Seres Therapeutics, Inc. [MCRB] share price is $8.74. The Score for MCRB is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
Seres Therapeutics, Inc. Stock Info
Market Cap:
76.5M
Price in USD:
8.74
Share Volume:
63.1K
Seres Therapeutics, Inc. 52-Week Range
52-Week High:
29.98
52-Week Low:
6.53
Sell
2
Seres Therapeutics, Inc. (MCRB)
is a Sell
Seres Therapeutics, Inc. Share Price Forecast
-
What is the Seres Therapeutics, Inc. stock price today?The Seres Therapeutics, Inc. stock price is 8.74 USD today.
-
Will MCRB stock go up or go down?Seres Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Seres Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seres Therapeutics, Inc. is overvalued.
Is Seres Therapeutics, Inc. Stock a Buy?
-
Seres Therapeutics, Inc. share price is 8.74 while MCRB 8-day exponential moving average is 10.12, which is a Sell signal.
-
The stock price of MCRB is 8.74 while Seres Therapeutics, Inc. 20-day EMA is 12.27, which makes it a Sell.
-
Seres Therapeutics, Inc. 50-day exponential moving average is 14.21 while MCRB share price is 8.74, making it a Sell technically.
-
MCRB stock price is 8.74 and Seres Therapeutics, Inc. 200-day simple moving average is 15.51, creating a Sell signal.
Fundamental Analysis of Seres Therapeutics, Inc.
Is Seres Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $4.48 per share, a decrease next quarter of $0.00 per share, a decrease this year of $8.74 per share, and a decrease next year of $0.91 per share.
Technical Analysis of Seres Therapeutics, Inc.
Should I short Seres Therapeutics, Inc. stock?
-
MCRB Moving Average Covergence Divergence (MACD) indicator is -1.79, suggesting Seres Therapeutics, Inc. is a Sell
-
Seres Therapeutics, Inc. Relative Strength Index (RSI) is 26.81, which suggest Seres Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Seres Therapeutics, Inc. is (10.93 - 16.33), which suggest Seres Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Seres Therapeutics, Inc. is (13.33 - 19.43), which suggest Seres Therapeutics, Inc. is a Sell
* Seres Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.